Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04851119
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
Recruiting
Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC
NCT04615143
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT06609850
- Conditions
- Ablation, Adenocarcinoma, Carcinoma, +13 more
- Locations
-
- Chinese PLA General hospital Beijing, None Selected, China
NCT01015833
- Conditions
- Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States
- Alaska Regional Hospital Anchorage, Alaska, United States
Completed
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
NCT02143401
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +34 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT02447679
- Conditions
- Adenocarcinoma, Adult Hepatocellular Carcinoma, Adverse Reaction to Drug, +14 more
- Locations
-
- Chang Gung Memorial Hospital Taoyuan, Taiwan
Completed
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion
NCT02728219
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Eastern hepatobilliary surgery hospital Shanghai, Shanghai Municipality, China
Completed
Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma
NCT02613156
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
Not specified
Active, Not Recruiting
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
NCT02867592
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Active, Not Recruiting
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
NCT03186898
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Emory Proton Therapy Center Atlanta, Georgia, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
Active, Not Recruiting
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
NCT03257761
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +45 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
NCT04514484
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
NCT03655002
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States